SKI Market

A+| A| A-|

Indian Indices

Sensex

77,562.90 2,946.32
( 3.95%)

Global Indices

Nasdaq

46,614.19 -76.70
(-0.16%)

Dow Jones

6,639.23 6.40
(0.10%)

Hang Seng

56,345.93 2,916.37
(5.46%)

Nikkei 225

10,352.49 -83.80
(-0.80%)

Forex

USD-INR

92.93 0.25
(0.27%)

EUR-INR

107.23 0.49
(0.46%)

GBP-INR

122.94 0.71
(0.58%)

JPY-INR

0.58 0.00
(0.32%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

411.5542386

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

21.2

97115.67

EPS(TTM)

Face Value()

Div & Yield %

56.72

1.33

Back

&hra pradesh state financial corpn ltd

GCCL Construction & Realities standalone net profit rises 342.86% in the September 2025 quarter

Nov 14,2025

Net profit of GCCL Construction & Realities rose 342.86% to Rs 0.31 crore in the quarter ended September 2025 as against Rs 0.07 crore during the previous quarter ended September 2024. Sales reported to Rs 0.37 crore in the quarter ended September 2025. There were no Sales reported during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	0.37	0	0
OPM %	89.19	0	-
PBDT	0.46	0.10	360
PBT	0.44	0.10	340
NP	0.31	0.07	343

77,562.90 2,946.32 ( 3.95%)

46,614.19 -76.70 (-0.16%)

6,639.23 6.40 (0.10%)

56,345.93 2,916.37 (5.46%)

10,352.49 -83.80 (-0.80%)

92.93 0.25 (0.27%)

107.23 0.49 (0.46%)

122.94 0.71 (0.58%)

0.58 0.00 (0.32%)